Accuray Incorporated fell 16.9% on Thursday, November 5, 2026, on 2,713,086 shares. Headlines around the move:
Accuray Incorporated (ARAY:NASDAQ) closed at $0.110 on November 6, 2026, down 11.22% on the day. The stock trades 91.3% below its 52-week high of $1.27 and 2.2% above its 52-week low of $0.108. Over the past year, it lost 90.6%. Accuray Incorporated is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since November 6, 2025, ARAY closed higher on 79 days (31%). Its best day was September 28, 2026 (+36.36%) and its worst was May 7, 2026 (-39.58%). The stock moved 10% or more in a single session 28 times. It opened at least 5% above the previous day's high 1 time.
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. The CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables delivery of precise, high dose radiation while patients breathe normally. It also offers the TomoTherapy System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. The company markets its products in the United States directly, as well as through a sales agent and group purchasing organizations; and directly and through distributors and sales agents in Europe, Japan and other countries of Asia, South America, and internationally to hospitals and stand-alone treatment facilities. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.
Find more stocks like ARAY with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.